by Team Small News | Jun 11, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals, a renowned drug company, has announced its plan to launch a cancer treatment drug called zanubrutinib, also known as Brukinsa, in India. The drug has been approved by the Drugs Controller General of India (DCGI) and will be used to treat five... by Team Small News | Jun 6, 2025 | Glenmark, Pharma
Glenmark, an Indian pharmaceutical company, recently reported its earnings for the 2025 financial year. While the company’s overall performance was affected by a weak second half in its India business, it is planning to revive growth in both its core markets:... by Team Small News | Jun 2, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals’ latest earnings report may appear impressive at first glance, but a closer examination reveals some underlying weaknesses. The company’s net profit increased by 15.6% year-over-year, reaching ₹2.16 billion, and revenue grew by... by Team Small News | May 24, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals has announced its financial results for the fourth quarter and full year ended March 2025, highlighting a solid profit growth despite increasing interest costs. The company’s performance was driven by robust sales across its key markets... by Team Small News | May 15, 2025 | Glenmark, Pharma
The Department of Transfusion Medicine at PGIMER, Chandigarh, recently conducted two blood donation camps in the city, with the goal of ensuring an adequate blood supply for patients in need. The first camp was held on May 14, 2025, at the Community Center in... by Team Small News | May 14, 2025 | Glenmark, Pharma
NIVEA India has appointed Akshay Kawale as the Business Unit Head of its Derma division, effective April 3, 2025. Kawale brings 16 years of experience in the industry, having worked with prominent organizations such as Glenmark Pharmaceuticals, Abbott, GSK, and...